Novan released its financial results for the first quarter of 2023, which included continued progress towards its prescription drug user fee act goal date for berdazimer gel 10.3%, according to a company press release. Novan announced its new drug application submission for berdazimer gel 10.3% for the treatment of molluscum contagiosum in January. The FDA accepted the application for filing and
Gilbert & Cook Inc. purchased a new stake in Johnson Controls International plc (NYSE:JCI – Get Rating) during the 4th quarter, Holdings Channel.com reports. The institutional investor purchased 5,752 shares of the company’s stock, valued at approximately $368,000. Several other institutional investors and hedge funds have also modified their holdings of JCI. Canton Hathaway LLC […]
15.05.2023 - – Continued progress toward PDUFA goal date of January 5, 2024, for berdazimer gel, 10.3% (SB206) – – Strong prescription growth across three promoted products – – Company to host conference call today at 8:30 a.m. ET – DURHAM, N.C., May 15, .
Saturna Capital CORP cut its holdings in shares of Johnson Controls International plc (NYSE:JCI – Get Rating) by 0.2% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,724,911 shares of the company’s stock after selling 2,743 shares during the quarter. Johnson Controls International […]
Mercer Global Advisors Inc. ADV raised its position in Johnson Controls International plc (NYSE:JCI – Get Rating) by 8.4% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 109,985 shares of the company’s stock after acquiring an additional 8,519 shares during the period. Mercer Global Advisors Inc. ADV’s […]